Chronic myeloid leukemia: A qualitative interview study exploring disease impact from patient and practitioner perspectives

Author:

Hewison Ann1,Roman Eve1,Smith Alexandra1,McCaughan Dorothy1,Sheridan Rebecca1,Patmore Russell2,Atkin Karl1,Howell Debra1

Affiliation:

1. University of York

2. Castle Hill Hospital

Abstract

AbstractPurposeImprovements in chronic myeloid leukaemia treatment mean it is now relevant to examine the experiences of living with this cancer over a lifetime. This qualitative study aimed to investigate the impact of chronic myeloid leukaemia, from patient and healthcare practitioner perspectives.MethodsThe research was set within the UK’s Haematological Malignancy Research Network; a population-based cohort of patients newly diagnosed with blood cancer, treated at one of fourteen hospitals. Purposive sampling led to interviews with seventeen patients and thirteen health care practitioners. Data were analysed using thematic analysis.ResultsTwo analytical themes, “Significant impact of disease and treatment” and “Mediators of the impact of disease and treatment”, along with six sub-themes, were derived from patient interviews, and supported with data from practitioners. Chronic myeloid leukaemia was described by patients as having significant and widespread impact, which could be mediated by their knowledge, social support networks, and the quality of healthcare systems. Practitioners reflected patient accounts, but could underestimate the impact of this cancer. They generally viewed chronic myeloid leukaemia as less complex, severe and impactful than acute blood cancers; a message that reassured patients at diagnosis, but could later unintentionally contribute to difficulties discussing side effects and struggles to cope.ConclusionChronic myeloid leukaemia may significantly impact individuals, particularly as it is experienced over the lifetime. Greater understanding and discussion of the breadth and extent to which patients are affected, including potential mediators, could enhance clinical care.

Publisher

Research Square Platform LLC

Reference58 articles.

1. Haematological Malignancy Research Network [Internet]. HMRN. 2022 [cited 2022 Jun 13]. Available from: https://www.hmrn.org/statistics/incidence

2. The chronic myeloid leukaemia story in the United Kingdom since 1960;Clark RE;British Journal of Haematology,2020

3. Baccarani M, Pane F. A Critical History of Chromic Myeloid Leukemia. Mediterr J Hematol Infect Dis [Internet]. 2014 Jan 2 [cited 2021 Mar 3];6(1). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894841/

4. Williams LA, Garcia Gonzalez AG, Ault P, Mendoza TR, Sailors ML, Williams JL, et al. Measuring the symptom burden associated with the treatment of chronic myeloid leukemia. Blood. 2013 Aug 1;122(5):641–7.

5. Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population;Efficace F;Blood. 2011 Oct

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3